Gregory O. Anglum - Feb 10, 2022 Form 4 Insider Report for Bioventus Inc. (BVS)

Role
SVP & CFO
Signature
/s/ Anthony D'Adamio, Attorney-in-Fact
Stock symbol
BVS
Transactions as of
Feb 10, 2022
Transactions value $
$253,401
Form type
4
Date filed
2/14/2022, 07:35 PM
Next filing
Feb 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BVS Class A Common Stock Options Exercise +65.6K +1093.02% 71.6K Feb 10, 2022 Direct F1
transaction BVS Class A Common Stock Tax liability $253K +19.7K +61.04% $12.88 51.9K Feb 10, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BVS Phantom Profit Units Options Exercise $0 -65.6K -100% $0.00* 0 Feb 10, 2022 Class A Common Stock 65.6K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.